Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.
Goldschmidt-Clermont
P J
PJ
Heart and Lung Institute, and Division of Cardiology, College of Medicine and Public Health, The Ohio State University, Columbus, Ohio, USA. goldschmidt-1@medctr.osu.edu
Roos
C M
CM
Cooke
G E
GE
D016824:Antigens, Human Platelet / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use*; D011110:Polymorphism, Genetic; D012307:Risk Factors; D013923:Thromboembolism / Q000150:complications* / Q000235:genetics*
D016824:Antigens, Human Platelet; D010975:Platelet Aggregation Inhibitors; C083451:human platelet antigen 1b